CRIS Current Research Information System

BELLUZZI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.004
EU - Europa 3.457
AS - Asia 3.418
SA - Sud America 220
AF - Africa 200
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.917
IT - Italia 1.378
SG - Singapore 986
VN - Vietnam 925
CN - Cina 678
SE - Svezia 449
GB - Regno Unito 396
DE - Germania 288
HK - Hong Kong 261
FR - Francia 172
BR - Brasile 166
IN - India 159
RU - Federazione Russa 148
IE - Irlanda 132
NL - Olanda 111
UA - Ucraina 71
KR - Corea 70
JP - Giappone 66
CI - Costa d'Avorio 59
CA - Canada 56
CH - Svizzera 52
BG - Bulgaria 48
TG - Togo 48
JO - Giordania 43
FI - Finlandia 42
ZA - Sudafrica 39
BD - Bangladesh 37
PH - Filippine 34
AT - Austria 29
AR - Argentina 27
BE - Belgio 26
EE - Estonia 26
ES - Italia 24
ID - Indonesia 20
SC - Seychelles 20
TH - Thailandia 20
TW - Taiwan 17
AU - Australia 16
TR - Turchia 16
MX - Messico 15
IR - Iran 13
PL - Polonia 13
SA - Arabia Saudita 11
GR - Grecia 10
IQ - Iraq 10
MY - Malesia 10
PK - Pakistan 9
BH - Bahrain 8
CL - Cile 8
RO - Romania 8
LT - Lituania 7
NG - Nigeria 7
KE - Kenya 6
UZ - Uzbekistan 6
CO - Colombia 5
EC - Ecuador 5
HR - Croazia 5
ET - Etiopia 4
HN - Honduras 4
HU - Ungheria 4
MA - Marocco 4
MU - Mauritius 4
BA - Bosnia-Erzegovina 3
BZ - Belize 3
EG - Egitto 3
LB - Libano 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
IL - Israele 2
LV - Lettonia 2
LY - Libia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SM - San Marino 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 11.313
Salva come PNG Salva come JPEG
Città #
Singapore 705
Ashburn 462
Chandler 408
Southend 313
Fairfield 246
Hong Kong 245
Houston 239
Hanoi 216
Ho Chi Minh City 216
San Jose 206
Santa Clara 185
Bologna 159
Dublin 126
Princeton 123
Seattle 123
Beijing 108
Ann Arbor 105
Woodbridge 102
Boardman 99
Cambridge 86
Wilmington 85
Rome 81
Milan 78
Hefei 77
Los Angeles 73
Lauterbourg 60
Abidjan 59
New York 56
Seoul 54
Berlin 51
Tokyo 50
Dong Ket 49
Lomé 48
Sofia 43
Amman 42
Buffalo 39
Council Bluffs 39
Dallas 38
São Paulo 37
Bern 34
Turin 32
Helsinki 31
Nanjing 31
Frankfurt am Main 30
Westminster 30
Haiphong 28
Padova 26
Da Nang 23
Falkenstein 22
Palermo 22
Jinan 21
San Diego 21
Toronto 21
Capaccio 20
Redondo Beach 20
Chicago 19
Orem 19
Brussels 18
Guangzhou 18
Phoenix 18
Bengaluru 17
Florence 17
Munich 16
Modena 15
Naples 15
Yubileyny 15
Hebei 14
Montreal 14
Shenyang 14
Vienna 14
Jiaxing 13
London 13
Redmond 13
Warsaw 13
Des Moines 12
Napoli 12
Pune 12
Saint Petersburg 12
San Francisco 12
Bremen 11
Shenzhen 11
Tianjin 11
Velletri 11
Bangkok 10
Bari 10
Changsha 10
Dearborn 10
Hải Dương 10
Jakarta 10
Johannesburg 10
Long Xuyen 10
Nuremberg 10
Paris 10
Perugia 10
Redwood City 10
Shanghai 10
Thái Nguyên 10
Atlanta 9
Can Tho 9
Castel Maggiore 9
Totale 6.509
Salva come PNG Salva come JPEG
Nome #
Polifenoli ed efficacia antinfiammatoria: lo strano caso del melograno e le malattie croniche intestinali 965
Risposta immunitaria verso Mycobacterium avium paratubercolosis (MAP) in pazienti affetti da Morbo di Crohn 390
Pomegranate: from the Promised Land to calm the fire in Inflammatory Bowel Disease 315
COVID-19 in IBD: The experience of a single tertiary IBD center 306
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 275
Inflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells 268
Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis 259
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 255
Can POSSUM accurately predict post-operative complications risk in patients with abdominal Crohn’s disease? 254
Clinical application of faecal calprotectin in ulcerative colitis patients 249
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 245
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. 242
New Insight and Knowledge on anti-inflammatory Effectiveness of dietary phenolics: a work-in-progress report of the NIKE Project 230
Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy 230
Intestinal epithelial cells in inflammatory bowel diseases 228
A Mediterranean Diet Mix Has Chemopreventive Effects in a Murine Model of Colorectal Cancer Modulating Apoptosis and the Gut Microbiota 228
IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. 227
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial 226
Highly Purified Eicosapentaenoic Acid as Free Fatty Acids Strongly Suppresses Polyps in ApcMin/+ Mice 215
Attachment and mentalizing abilities in patients with inflammatory bowel disease 211
Influence of steroid treatment's duration in patients with active Crohn's disease 206
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch–Anal Anastomosis for Ulcerative Colitis 200
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. 196
Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn’s disease, cause or epiphenomenon? 190
Inflammatory bowel disease: Moving toward a stem cell-based therapy 188
New proteomic approaches for biomarker discovery in inflammatory bowel disease 185
Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota 185
Evidence for a Modulatory Effect of a 12‐Week Pomegranate Juice Intervention on the Transcriptional Response in Inflammatory Bowel Disease Patients Reducing Fecal Calprotectin Levels: Findings From a Proof‐of‐Principle Study 180
The Effect of Supplementing a Novel n-3 Polyunsaturated Fatty Acids Formulation Containing Schisandra chinensis Extract and Vitamin D3 to a Group of Elite Sport Athletes on Competition Related Stress, Anxiety and Self-confidence 180
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 168
Aortic thrombosis recurrence in a Crohn's disease patient 162
New Insight and Knowledge on anti-inflammatory Effectiveness of dietary phenolics: the NIKE Project 159
A proposed staging system and stage-specific interventions for familial adenomatous polyposis 156
Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection 148
PROBABILISTIC ASSESSMENT OF SYMPTOMLESS INFLAMMATION IN CROHN’S DISEASE PATIENTS 146
null 139
p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis 128
Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis 124
Analysis of biological variables in Crohn's disease [4] 120
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 118
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 108
A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells. 106
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 106
Interleukin 1 in ulcerative colitis 106
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 105
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 104
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 103
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion 101
Role of rectal formulations: Enemas 100
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 100
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 97
Macrophage subpopulations in pouchitis 97
Bronchopulmonary involvement in ulcerative colitis 97
null 95
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 95
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 93
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 91
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 91
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 90
Pentasa in maintenance treatment of ulcerative colitis 89
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 89
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 87
MRI patterns in a case of 6-thioguanine-related hepatic sinusoidal obstruction syndrome 85
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration 84
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 83
Affective EEG Decoding Generalizes Across Colormap and Exposure Time 55
Totale 11.553
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021199 0 0 0 0 0 0 0 0 0 0 0 199
2021/20221.230 42 42 58 95 83 47 41 51 129 106 349 187
2022/20231.608 146 248 121 176 95 125 70 106 280 43 103 95
2023/2024584 43 70 64 56 58 107 37 32 29 48 19 21
2024/20251.849 111 210 142 112 295 98 173 90 46 131 92 349
2025/20263.913 403 299 295 269 362 222 376 168 917 332 114 156
Totale 11.553